Zacks Research downgraded shares of Constellium (NYSE:CSTM – Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Tuesday morning,Zacks reports.
CSTM has been the topic of several other reports. Wells Fargo & Company dropped their target price on Constellium from $39.00 to $38.00 and set an “overweight” rating on the stock in a research report on Friday, September 18th. Weiss Ratings reissued a “hold (c+)” rating on shares of Constellium in a research note on Monday, September 28th. Deutsche Bank Aktiengesellschaft set a $39.00 price objective on Constellium in a report on Thursday, July 30th. Finally, UBS Group cut their price objective on shares of Constellium from $38.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, July 8th. Four equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $34.40.
Check Out Our Latest Stock Analysis on Constellium
Constellium Trading Up 0.8%
Constellium (NYSE:CSTM – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.18. Constellium had a net margin of 5.69% and a return on equity of 51.66%. The business had revenue of $2.75 billion for the quarter, compared to the consensus estimate of $2.73 billion. During the same period in the prior year, the business posted $0.25 earnings per share. Constellium’s revenue for the quarter was up 30.7% compared to the same quarter last year. On average, equities analysts expect that Constellium will post 3.7 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, Director Jean-Christophe Deslarzes purchased 1,490 shares of Constellium stock in a transaction on Monday, August 3rd. The stock was bought at an average price of $27.24 per share, with a total value of $40,587.60. Following the completion of the transaction, the director directly owned 43,515 shares of the company’s stock, valued at approximately $1,185,348.60. This represents a 3.55% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.20% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Constellium
A number of large investors have recently added to or reduced their stakes in the stock. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Constellium by 620.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company’s stock worth $79,345,000 after buying an additional 2,780,260 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Constellium by 894.4% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,056,336 shares of the industrial products company’s stock worth $50,545,000 after acquiring an additional 1,849,554 shares during the period. SG Americas Securities LLC lifted its position in Constellium by 53.6% during the 1st quarter. SG Americas Securities LLC now owns 1,497,460 shares of the industrial products company’s stock worth $36,808,000 after acquiring an additional 522,725 shares during the last quarter. Bank of America Corp DE lifted its position in Constellium by 100.1% during the 1st quarter. Bank of America Corp DE now owns 851,222 shares of the industrial products company’s stock worth $20,923,000 after acquiring an additional 425,871 shares during the last quarter. Finally, Encompass Capital Advisors LLC boosted its holdings in Constellium by 9.2% during the fourth quarter. Encompass Capital Advisors LLC now owns 4,657,915 shares of the industrial products company’s stock valued at $87,802,000 after acquiring an additional 393,640 shares during the period. Institutional investors own 92.59% of the company’s stock.
Constellium Company Profile
Constellium SE (NYSE: CSTM) is a global manufacturer of advanced aluminum products and solutions. The company develops, engineers and produces aluminum rolled, extruded and shaped products for customers in the aerospace, automotive, packaging and industrial markets.
Its products include aluminum sheets, plates, coils, extrusions, structural components and automotive body systems. Constellium also supplies aluminum products used in beverage cans, bottles and other packaging applications, as well as components for aircraft structures, automotive vehicles, commercial transportation and industrial equipment.
Constellium serves customers through manufacturing and research operations across Europe, North America and Asia.
Further Reading
- Five stocks we like better than Constellium
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.
